loading page

Backstory of:  A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density
  • Profile pic
  • Backstories,
  • Robert Recker
Backstories
Backstories
Author Profile
Profile pic
Robert Recker
Creighton University
Author Profile